Acutus Medical Inc
(NASDAQ:AFIB)
$0.2494
0.0093[3.87%]
Last update: 4:20PM (Delayed 15-Minutes)
Get Real Time Here
$0.2494
0[0.00%]
After-Hours
Open0.245Close0.237
Vol / Avg.105.718K / 498.705KMkt Cap7.308M
Day Range0.233 - 0.25052 Wk Range0.160 - 1.960

Acutus Medical Stock (NASDAQ:AFIB), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Neutral

Highest Price Target1

$3.00

Lowest Price Target1

$1.50

Consensus Price Target1

$1.00

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
10310

Analyst Firms Making Recommendations1

  • Goldman Sachs
  • BTIG
  • Canaccord Genuity
  • JP Morgan
  • William Blair

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Acutus Medical

Upgrades (2)

Downgrades (6)

Initiations (1)

date
▲▼
ticker
▲▼
Buy Now
Company
▲▼
Current price
▲▼
Upside/Downside
▲▼
Analyst Firm
▲▼
Analyst & % Accurate
▲▼
Price Target Change
▲▼
Rating Change
▲▼
Previous / Current Rating
▲▼
Get Alert
08/16/2022AFIBBuy Now
Acutus Medical
$0.25501.44%Goldman Sachs
Amit Hazan
$1 → $1.5MaintainsNeutralGet Alert
06/24/2022AFIBBuy Now
Acutus Medical
$0.25501.44%BTIG
Marie Thibault
$2 → $1.5MaintainsBuyGet Alert
04/27/2022AFIBBuy Now
Acutus Medical
$0.25701.92%BTIG
Marie Thibault
→ $2UpgradeNeutral → BuyGet Alert
04/14/2022AFIBBuy Now
Acutus Medical
$0.25300.96%Goldman Sachs
Amit Hazan
$5 → $1MaintainsNeutralGet Alert
01/20/2022AFIBBuy Now
Acutus Medical
$0.25—BTIG
Marie Thibault
—DowngradeBuy → NeutralGet Alert
01/14/2022AFIBBuy Now
Acutus Medical
$0.251102.89%Canaccord Genuity
William Plovanic
$10 → $3DowngradeBuy → HoldGet Alert
11/12/2021AFIBBuy Now
Acutus Medical
$0.25—JP Morgan
Robbie Marcus
—DowngradeNeutral → UnderweightGet Alert
11/12/2021AFIBBuy Now
Acutus Medical
$0.253909.62%Canaccord Genuity
William Plovanic
—MaintainsBuyGet Alert
10/22/2021AFIBBuy Now
Acutus Medical
$0.253909.62%Goldman Sachs
Amit Hazan
—Initiates → NeutralGet Alert
07/15/2021AFIBBuy Now
Acutus Medical
$0.257117.32%Canaccord Genuity
William Plovanic
—UpgradeHold → BuyGet Alert
03/19/2021AFIBBuy Now
Acutus Medical
$0.256315.4%Canaccord Genuity
William Plovanic
—MaintainsHoldGet Alert
03/19/2021AFIBBuy Now
Acutus Medical
$0.25—William Blair
Margaret Kaczor
—DowngradeOutperform → Market PerformGet Alert
03/19/2021AFIBBuy Now
Acutus Medical
$0.257518.28%JP Morgan
Robbie Marcus
—DowngradeOverweight → NeutralGet Alert
01/14/2021AFIBBuy Now
Acutus Medical
$0.25—B of A Securities
Bob Hopkins
—DowngradeBuy → NeutralGet Alert
Q

What is the target price for Acutus Medical (AFIB)?

A

The latest price target for Acutus Medical (NASDAQ: AFIB) was reported by Goldman Sachs on August 16, 2022. The analyst firm set a price target for $1.50 expecting AFIB to rise to within 12 months (a possible 501.44% upside). 0 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Acutus Medical (AFIB)?

A

The latest analyst rating for Acutus Medical (NASDAQ: AFIB) was provided by Goldman Sachs, and Acutus Medical maintained their neutral rating.

Q

When is the next analyst rating going to be posted or updated for Acutus Medical (AFIB)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Acutus Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Acutus Medical was filed on August 16, 2022 so you should expect the next rating to be made available sometime around August 16, 2023.

Q

Is the Analyst Rating Acutus Medical (AFIB) correct?

A

While ratings are subjective and will change, the latest Acutus Medical (AFIB) rating was a maintained with a price target of $1.00 to $1.50. The current price Acutus Medical (AFIB) is trading at is $0.25, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.